Quick-Med Technologies to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto
Quick-Med Technologies zu myNews hinzufügen Was ist das?
Quick-Med Technologies, Inc. (OTCBB:QMDT) announced that the company
will participate in the Third Congress of the World Union of Wound
Healing Societies being held in Toronto, Ontario on June 4-8, 2008.
Three poster abstracts have been accepted for presentation:
"Absorbent Microbicidal Wound
Dressing Material with Protease Inhibitor Properties” – B. Liesenfeld, G. Schultz, J. Azeke, O.
Moloye, W. Toreki, D. Moore, J. Olderman and R. Carr; Quick-Med
Technologies, Inc. and the University of Florida at Gainesville.
"Protease Inhibitors Prevent Microvesication in Sulfur Mustard Wounds
on Human Skin Explant" - B. Liesenfield, M. Mol and G. Schultz;
Quick-Med Technologies, Inc., TNO Laboratories, Netherlands and the
University of Florida at Gainesville.
"Persistent Skin Sanitizer with Sustained Microbicidal Properties"
- W. Toreki, D. Moore, B. Liensenfield, J. Vella, G. Schultz, J.
Olderman and R. Carr; Quick-Med Technologies, Inc. and the University of
Florida at Gainesville.
"We are pleased to have our NIMBUS®,
NimbuDerm™ and MultiStat™
technologies selected for presentation at this prestigious wound care
event," said J. Ladd Greeno, Chief Executive Officer of Quick-Med
Technologies.
Quick-Med Technologies is developing advanced solutions for wound care
market. Wound care is a $10 billion market, with continued growth being
driven by an aging population, the rise in the incidence of diabetes
worldwide, and a steady advancement in more clinically efficient and
cost-effective technology and products.
To schedule a meeting with Quick-Med Technologies, please contact Roy D.
Carr, Director of Business Development - Medical Devices at
561-771-1306, or rcarr@quickmedtech.com.
About Third Congress of the World Union of Wound Healing Societies
The primary goal of the World Union of Wound Healing Societies 2008
Congress, sponsored and hosted by the University of Toronto, will be to
present the wound care evidence base and transfer the knowledge, skills,
and attitudes for improved patient outcomes. This will be accomplished
through a five-day meeting that includes a pre-conference day, three
plenary sessions, and 10 concurrent streams with more than 100
educational sessions. For more information, see: www.wuwhs2008.com. About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is
developing innovative technologies for the healthcare and consumer
markets. For more information, see: www.quickmedtech.com.
© 2008 Quick-Med Technologies, Inc. All rights
reserved. NIMBUS® is a registered trademark
and NimbuDerm™ and MultiStat are trademarks
of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical
facts) in this release are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. For this
purpose, any statements contained in this release that are not
statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words such
as "may", "will", "to", "expect", "plan", "believe", "anticipate",
"intend", "could", "would", "estimate", and/or "continue" or the
negative or other variations thereof or comparable terminology is
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the Company's
filings with the Securities and Exchange Commission ("SEC"), which may
be accessed at the SEC's Edgar System at www.sec.gov.
